![Carl Walkey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Walkey is the founder of Ansible Marketing, Inc. (founded in 2014) and Neoleukin Therapeutics, Inc. (founded in 2003).
At Neoleukin Therapeutics, he held the title of Senior Vice President-Corporate Development from 2021 to 2022.
Dr. Walkey earned a doctorate degree from the University of Toronto.
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROGENE INC. | Fondateur | 01/12/2022 |
Ansible Marketing, Inc. | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
Ansible Marketing, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
